StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.73−0.06 (-2.32%)

Close on Nov 17, 2026Market cap $117.46MP/E –Yield –

Pulmonx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Pulmonx's operating cash flow for the twelve months ending Jun 30, 2026 was -$30.56M. For fiscal 2025 it was -$32.38M. The highest annual figure on record is -$18.39M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$32.38M–
FY2024Dec 31, 2024-$31.54M–
FY2023Dec 31, 2023-$37.61M–
FY2022Dec 31, 2022-$45.08M–
FY2021Dec 31, 2021-$41.39M–
FY2020Dec 31, 2020-$30.63M–
FY2019Dec 31, 2019-$20.77M–
FY2018Dec 31, 2018-$18.39M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.21M–
Q1 FY2026Mar 31, 2026-$10.10M–
Q4 FY2025Dec 31, 2025-$7.08M–
Q3 FY2025Sep 30, 2025-$8.16M–
Q2 FY2025Jun 30, 2025-$3.91M–
Q1 FY2025Mar 31, 2025-$13.22M–
Q4 FY2024Dec 31, 2024-$6.73M–
Q3 FY2024Sep 30, 2024-$7.24M–
Q2 FY2024Jun 30, 2024-$5.77M–
Q1 FY2024Mar 31, 2024-$11.80M–
Q4 FY2023Dec 31, 2023-$8.45M–
Q3 FY2023Sep 30, 2023-$8.63M–
Q2 FY2023Jun 30, 2023-$7.89M–
Q1 FY2023Mar 31, 2023-$12.64M–
Q4 FY2022Dec 31, 2022-$9.81M–
Q3 FY2022Sep 30, 2022-$10.69M–
Q2 FY2022Jun 30, 2022-$9.56M–
Q1 FY2022Mar 31, 2022-$15.03M–
Q4 FY2021Dec 31, 2021-$10.71M–
Q3 FY2021Sep 30, 2021-$8.32M–
Q2 FY2021Jun 30, 2021-$12.69M–
Q1 FY2021Mar 31, 2021-$9.67M–
Q4 FY2020Dec 31, 2020-$7.26M–
Q3 FY2020Sep 30, 2020-$5.83M–
Q2 FY2020Jun 30, 2020-$7.69M–
Q1 FY2020Mar 31, 2020-$9.85M–
Q4 FY2019Dec 31, 2019-$3.47M–

More Pulmonx figures

See a number that looks wrong?